Mayo Clinic

Government affairs firm

Based in DC

🤖

AI Overview

With $1.2M in lobbying spend across 24 quarterly filings, Mayo Clinic is a significant lobbying presence. They deploy 31 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$1.2M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$180K
2019	$180K
2020	$150K
2021	$70K
2022	$180K
2024	$240K
2025	$180K

Issues Lobbied

Medicare/Medicaid Health Issues Budget/Appropriations Veterans Copyright/Patent

Lobbying Firms

Mehlman Consulting, INC.

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Budget/Appropriations, Veterans, Copyright/Patent

Quality payments for providers; clinical laboratory reimbursement; physician payment policies; chronic healthcare.

H.R. 6 - SUPPORT for Patients and Communities Act.

S. 3120 - HEAL Act of 2018.

General healthcare; health reform implementation; healthcare value and quality; health information technology, clinical trials, telehealth.

Precision Medicine Act of 2016.

Promoting biomedical research.

H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

S. 3120 - Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018.

S. 2680 - Opioid Crisis Response Act of 2018.

Fiscal Year 2018 Labor and Health and Human Services Appropriations.

Fiscal Year 2019 Labor and Health and Human Services Appropriations.

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability.

Promoting biomedical research.

Opioid addiction and treatment.

International reimbursement issues.

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability.

Promoting biomedical research.

Opioid addiction and treatment.

S. 1895: Lower Health Care Costs Act.

Patent issues impacting clinical laboratory innovation.

General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability.

Promoting biomedical research.

Opioid addiction and treatment.

International reimbursement issues.

Rural health.

Reimbursement issues.

Showing 8 of 20 unique descriptions from filings.